S

    Sensus Healthcare Inc (SRTS)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $3.54
    +0.02 (+0.57%)

    Market Cap: $57.95M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    63%(25/40)
    Avg Surprise
    -26.71%

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-0.04
    Range$-0.08 - $0.02
    3 analysts
    EPS RevisionsNo revisions (7d)
    0
    1
    30d
    EPS Estimate Drift
    90d ago$-0.05-7.9%
    60d ago$-0.05-7.9%
    30d ago$-0.06-46.2%
    7d ago$-0.06-46.2%
    Current$-0.04
    Revenue Consensus
    $7M
    Range$5M - $9M
    4 analysts
    Dec 31, 2026
    EPS Consensus$-0.50
    Range$-0.56 - $-0.40
    3 analysts
    Revenue Consensus
    $3M
    Range$62000 - $5M
    4 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.50---
    Sep 26EST
    		-$-0.04---
    Jun 26
    		$-0.18$-0.11-63.64%Miss-200.0%
    Mar 26
    		$-0.16$-0.11-45.45%Miss+0.0%
    Dec 25
    		$-0.19$-0.05-280.00%Miss-311.1%
    Sep 25
    		$-0.06$-0.11+45.45%Beat-185.7%
    Jun 25
    		$-0.06$0.01-700.00%Miss-160.0%
    Mar 25
    		$-0.16$0.04-500.00%Miss-214.3%
    Dec 24
    		$0.09$0.12-25.00%Miss-65.4%
    Sep 24
    		$0.07$-0.01+800.00%Beat+177.8%
    Jun 24
    		$0.10$0.03+233.33%Beat+600.0%
    Mar 24
    		$0.14$-0.04+450.00%Beat+216.7%
    Dec 23
    		$0.26$0.14+85.71%Beat+52.9%
    Sep 23
    		$-0.09$-0.02-350.00%Miss-181.8%
    Jun 23
    		$-0.02N/A+75.00%Beat-109.5%
    Mar 23
    		$-0.12$0.13-192.31%Miss-112.4%
    Dec 22
    		$0.17$0.23-26.09%Miss-46.9%
    Sep 22
    		$0.11$0.13-15.38%Miss+1000.0%
    Jun 22
    		$0.21$0.13+61.54%Beat+1150.0%
    Mar 22
    		$0.97$0.40+142.50%Beat+1485.7%
    Dec 21
    		$0.32$0.16+100.00%Beat+1500.0%
    Sep 21
    		$0.01$-0.02+150.00%Beat+107.1%
    Jun 21
    		$-0.02N/A+66.67%Beat+87.5%
    Mar 21
    		$-0.07$-0.11+36.36%Beat+68.2%
    Dec 20
    		$0.02N/A+118.18%Beat-66.7%
    Sep 20
    		$-0.14$-0.14+0.00%Beat-250.0%
    Jun 20
    		$-0.16$-0.19+15.79%Beat-1700.0%
    Mar 20
    		$-0.22$-0.07-214.29%Miss-69.2%
    Dec 19
    		$0.06$0.03+100.00%Beat+500.0%
    Sep 19
    		$-0.04$-0.03-33.33%Miss-33.3%
    Jun 19
    		$0.01N/A+125.00%Beat+125.0%
    Mar 19
    		$-0.13$-0.03-333.33%Miss-62.5%
    Dec 18
    		$0.01$-0.01+200.00%Beat+133.3%
    Sep 18
    		$-0.03$-0.06+50.00%Beat+57.1%
    Jun 18
    		$-0.04$-0.05+20.00%Beat+33.3%
    Mar 18
    		$-0.08$-0.03-166.67%Miss+33.3%
    Dec 17
    		$-0.03N/A+62.50%Beat-1300.0%
    Sep 17
    		$-0.07$-0.07+0.00%Beat-2943.5%
    Jun 17
    		$-0.06N/A+53.85%Beat-
    Mar 17
    		$-0.12$0.01-1300.00%Miss-
    Dec 16
    		$0.00N/A+108.33%Beat-
    Sep 16
    		$-0.00N/A+77.00%Beat-

    Key Metrics

    Valuation
    P/E Ratio-6.00EV/EBITDA8.68x
    Price/FCF-8.36xFCF Yield-11.96%
    Profitability
    Profit Margin-88.40%Operating Margin-138.90%
    ROE-34.80%ROICN/A
    Financial Health
    Debt/EquityN/AInterest Coverage-8.68x
    Current Ratio8.71xQuick Ratio4.44x
    Trading Statistics
    Beta1.12Avg Volume41.57K
    52-Week High$5.4952-Week Low$2.66

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$3.31
    SMA 20$3.17
    SMA 50$3.06
    SMA 200$3.78
    EMA 10$3.34
    EMA 20$3.23
    EMA 50$3.15
    EMA 200$3.57

    MACD

    Line: 0.12Signal: 0.08Hist: 0.05

    ADX

    ADX: 24.2+DI: 31.4-DI: 14.5

    Aroon & PSAR

    Aroon Up100.0
    Aroon Down56.0
    PSAR$3.00

    Bollinger Bands

    Upper Band$3.59
    Lower Band$2.74
    %B Position2687%(Upper)
    Band Width0.94

    RSI (14-Day)

    Neutral
    66.7

    Momentum Oscillators

    Stoch %K85.0
    Stoch %D81.1
    Williams %R-18.7
    ROC (10d)22.1%
    Momentum0.64
    CCI (20d)173.8
    MFI (14d)87.6

    Volatility Measures

    ATR (14d)$0.20(5.6%)
    StdDev (20d)0.21
    Hist Vol55.2%(High)

    Volume Flow

    VWAP$3.58
    OBV666.8K
    AD Line422.0K
    CMF (20d)0.197

    Volume Metrics

    Avg Vol (20d)42.7K
    Vol Ratio3.3x(High)
    VWMA (20d)$3.28

    Pivot Points

    R3$4.00
    R2$3.79
    R1$3.65
    Pivot Point$3.45
    S1$3.31
    S2$3.10
    S3$2.97

    Advanced Oscillators

    TSI23.15
    Ultimate Osc65.9
    KST94.16

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$2.29M$3.39M$4.94M$6.88M$7.32M$8.34M$13.07M$8.84M$9.24M$10.66M$12.57M$3.90M
    Cost of Revenue$1.52M$2.40M$3.04M$4.17M$4.41M$3.99M$5.96M$3.60M$3.82M$4.00M$4.74M$1.91M
    Gross Profit$769,000$991,000$1.90M$2.71M$2.90M$4.35M$7.11M$5.24M$5.42M$6.66M$7.83M$1.99M
    Operating Expenses$3.95M$5.35M$5.05M$5.28M$4.85M$7.00M$5.38M$3.75M$3.44M$3.77M$2.25M$3.88M
    R&D$1.11M$1.59M$1.88M$1.82M$1.47M$2.61M$1.56M$863,000$866,000$926,000$675,000$1.08M
    SG&A$1.79M$2.04M$1.76M$1.92M$1.99M$2.21M$2.42M$1.57M$1.58M$1.58M$952,000$1.51M
    Operating Income$-3,180,000$-4,358,000$-3,149,000$-2,569,000$-1,943,000$-2,646,000$1.73M$1.50M$1.98M$2.89M$5.58M$-1,895,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$277,000
    Interest Expense$-117,000$-125,000$-156,000$-160,000$-183,000$-184,000$-230,000$-279,000$-209,000$-214,000$0$0
    Income Before Tax$-3,063,000$-4,233,000$-2,993,000$-2,409,000$-1,760,000$-2,462,000$1.96M$1.77M$2.19M$3.10M$5.81M$-1,576,000
    Income Tax Expense$5.69M$-1,607,000$174,000$-1,466,000$-723,000$110,000$410,000$559,000$579,000$827,000$1.60M$-125,000
    Net Income$-8,749,000$-2,626,000$-3,167,000$-943,000$-1,037,000$-2,572,000$1.55M$1.22M$1.61M$2.27M$4.21M$-1,451,000
    EBITDA$-3,033,000$-4,200,000$-2,985,000$-2,410,000$-1,785,000$-2,501,000$1.86M$1.60M$2.06M$3.00M$5.68M$-1,747,000
    EBIT$-3,180,000$-4,358,000$-3,149,000$-2,569,000$-1,943,000$-2,646,000$1.73M$1.50M$1.98M$2.89M$5.58M$-1,853,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about SRTS

    News

    Sensus Healthcare director Eric Sachetta buys $112,904 in stock By Investing.com

    Eric Sachetta, a director at Sensus Healthcare (SRTS), recently purchased 34,697 shares of company stock for $112,904, increasing his direct holdings to 209,310 shares. This insider buy follows a 16% stock return over the past week, despite the company reporting a significant earnings and revenue miss in Q2 2026 due to financing delays, which management expects to improve in the latter half of the year.

    Investing.com Nigeria•8/25/26•
    Neutral

    3 Promising Penny Stocks With Over $50M Market Cap

    This article highlights three promising penny stocks with market caps over $50 million: Sensus Healthcare (SRTS), MediciNova (MNOV), and Protalix BioTherapeutics (PLX). It provides a financial overview and growth prospects for each, emphasizing that while penny stocks carry risk, those with strong financials can offer opportunities. The report encourages investors to conduct further due diligence and notes that the information is not financial advice.

    Simply Wall Street•8/25/26•
    Somewhat-Bearish

    Sensus Healthcare (SRTS) director adds 31K shares

    Sensus Healthcare director Eric Sachetta purchased 31,000 shares of common stock in open-market transactions on August 20 and 21, 2026, totaling approximately $98,000. These purchases were not made under a Rule 10b5-1 trading plan, and he now directly holds 174,613 shares, with an additional 2,093 shares held indirectly through his spouse. This insider activity indicates a positive sentiment towards the company from a director.

    Stock Titan•8/24/26•
    Bullish

    We Think Sensus Healthcare (NASDAQ:SRTS) Can Afford To Drive Business Growth

    Sensus Healthcare (NASDAQ:SRTS) is analyzed for its cash burn and financial runway. The company had US$15m in cash and no debt in June 2026, with an annual cash burn of US$7.0m, providing a cash runway of 2.2 years. Despite a 53% drop in operating revenue over the last year, its relatively low cash burn percentage (13%) compared to its market capitalization suggests it could raise additional funds without significant dilution, mitigating immediate concerns about its financial viability.

    Sahm•8/23/26•
    Neutral

    Sensus Healthcare Reports Q2 2026 Financial Results with Significant Revenue Decline

    Sensus Healthcare (SRTS) reported a substantial 68.5% year-over-year revenue decline to $2.3 million in Q2 2026, selling only 11 units, leading to an $8.7 million net loss. The company is pivoting to direct sales and recurring revenue models, aiming to deliver over 20 units in Q3, while analysts maintain a "Moderate Buy" rating with price targets around $6.00-$8.00. This shift is expected to adapt its business model to market changes and seek long-term growth potential.

    Intellectia AI•8/20/26•
    Neutral

    Frequently Asked Questions About SRTS

    Does SRTS pay dividends?
    Sensus Healthcare Inc (SRTS) does not currently pay a regular dividend.
    What is SRTS's market cap?
    Sensus Healthcare Inc (SRTS) has a market capitalization of $57.95M with a current stock price of $3.54.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In